0001250853-21-000039.txt : 20210318
0001250853-21-000039.hdr.sgml : 20210318
20210318163527
ACCESSION NUMBER: 0001250853-21-000039
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210317
FILED AS OF DATE: 20210318
DATE AS OF CHANGE: 20210318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bevers Denise
CENTRAL INDEX KEY: 0001593865
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36225
FILM NUMBER: 21754815
MAIL ADDRESS:
STREET 1: C/O KINDRED BIOSCIENCES, INC.
STREET 2: 1555 BAYSHORE HIGHWAY, SUITE 200
CITY: BURLINGAME
STATE: CA
ZIP: 94010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kindred Biosciences, Inc.
CENTRAL INDEX KEY: 0001561743
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461160142
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1555 BAYSHORE HIGHWAY, SUITE 200
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 650-701-7901
MAIL ADDRESS:
STREET 1: 1555 BAYSHORE HIGHWAY, SUITE 200
CITY: BURLINGAME
STATE: CA
ZIP: 94010
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2021-03-17
0
0001561743
Kindred Biosciences, Inc.
KIN
0001593865
Bevers Denise
C/O KINDRED BIOSCIENCES, INC.
1555 BAYSHORE HIGHWAY, SUITE 200
BURLINGAME
CA
94010
1
0
0
0
Common Stock
2021-03-17
4
M
0
8396
0.32
A
8396
I
By SD Scientific, Inc.
Common Stock
2021-03-17
4
S
0
8396
5.002
D
0
I
By SD Scientific, Inc.
Common Stock
143835
D
Stock Option (right to buy)
0.32
2021-03-17
4
M
0
8396
0
D
2013-05-09
2023-05-09
Common Stock
8396
0
I
By SD Scientific, Inc.
Held by SD Scientific, Inc. ("SD Scientific"). The Reporting Person is a co-director and co-stockholder of SD Scientific and, as such shares voting and dispositive power over such shares held by SD Scientific but disclaims beneficial ownership of the shares except to the extent of her pecuniary interest therein.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 16, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.015, inclusive. The Reporting Person undertakes to provide to Kindred Biosciences, Inc., any security holder of Kindred Biosciences, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
/s/ Denise Bevers
2021-03-18